藤本隆史

Takashi Fujimoto

所属機関・部署：

研究分野 (1件)：脳神経外科学

競争的資金等の研究課題 (4件)：

論文 (31件)：

Takashi Fujimoto, Lindsey Williams, Daniel Quaranta, Riley Weaver, William Banks, Michelle Erickson. Regulation of CCL2 transport across the blood-brain barrier. Brain, Behavior, and Immunity. 2023. 114. 62-62
Lindsey M. Williams, Takashi Fujimoto, Riley R. Weaver, May J. Reed, Michelle A. Erickson. Heparan sulfate-dependent transport of CCL2 across an in vitro model of the human blood-brain barrier. 2023
Takashi Fujimoto, Michelle A. Erickson, William A. Banks. Neurotropism and blood-brain barrier involvement in COVID-19. Frontiers in Drug Delivery. 2022. 2
Daniel V. Quaranta, Riley R. Weaver, Kristen K. Baumann, Takashi Fujimoto, Lindsey M. Williams, Hyung Chan Kim, Aric F. Logsdon, Mohamed Omer, May J. Reed, William A. Banks, et al. Transport of the Proinflammatory Chemokines C-C Motif Chemokine Ligand 2 (MCP-1) and C-C Motif Chemokine Ligand 5 (RANTES) across the Intact Mouse Blood-Brain Barrier Is Inhibited by Heparin and Eprodisate and Increased with Systemic Inflammation. Journal of Pharmacology and Experimental Therapeutics. 2022. 384. 1. 205-223
Kei Sato, Shinsuke Nakagawa, Yoichi Morofuji, Yuki Matsunaga, Takashi Fujimoto, Daisuke Watanabe, Tsuyoshi Izumo, Masami Niwa, Fruzsina R Walter, Judit P Vigh, et al. Effects of fasudil on blood-brain barrier integrity. Fluids and barriers of the CNS. 2022. 19. 1. 43-43

MISC (1件)：

諸藤陽一, 中川慎介, 藤本隆史, 佐藤慧, 松永裕希, 堀江信貴, 出雲剛, 松尾孝之. 急性期脳梗塞治療としてのファスジル動注療法の可能性. 脳血管内治療(Web). 2020. 5. Supplement

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

藤本 隆史